We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Hold on to Equifax (EFX) Stock For Now
Read MoreHide Full Article
Equifax Inc.’s (EFX - Free Report) shares have charted a solid trajectory over the past year, appreciating 67.9% against 6.2% decline of the industry it belongs to and 34.8% rally of the Zacks S&P 500 index.
The company has a long-term (three to five years) expected EPS growth rate of 14.8%. Its earnings are expected to register 6.9% growth in 2021 and 21.3% in 2022.
Equifax has an impressive Growth Score of B. This style score condenses all the essential metrics from a company’s financial statements to get a true sense of the quality and sustainability of its growth.
Equifax serves a wide range of industries, such as financial, mortgage, consumer, employees, telecommunications, automotive, commercial, retail, government, resellers and others. This diversified client base is extremely beneficial, as weakness in any sector can be balanced with strength in the others.
The company’s top line has shown decent growth rates in the past few years. Total revenues have increased at a compounded annual growth rate of 5.6% from 2016 to 2020. Revenues improved 26% year over year in the second quarter of 2021.
We believe synergies from acquisitions, in addition to continued general consumer credit activity, product innovation, initiatives to foster enterprise growth and efficient business executions, will continue to drive Equifax’s revenues over the long run.
Some Risks
Equifax’s cash and cash equivalent of $458 million at the end of the second quarter was well below the long-term debt level of $3.3 billion, underscoring that the company does not have enough cash to meet this debt burden. The cash level cannot even meet the short-term debt of $601 million.
The long-term expected earnings per share (three to five years) growth rate for ManpowerGroup, Cross Country Healthcare and Genpact is pegged at 24.2%, 9.9% and 14.7%, respectively
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Here's Why You Should Hold on to Equifax (EFX) Stock For Now
Equifax Inc.’s (EFX - Free Report) shares have charted a solid trajectory over the past year, appreciating 67.9% against 6.2% decline of the industry it belongs to and 34.8% rally of the Zacks S&P 500 index.
The company has a long-term (three to five years) expected EPS growth rate of 14.8%. Its earnings are expected to register 6.9% growth in 2021 and 21.3% in 2022.
Equifax has an impressive Growth Score of B. This style score condenses all the essential metrics from a company’s financial statements to get a true sense of the quality and sustainability of its growth.
Equifax, Inc. Price, Consensus and EPS Surprise
Equifax, Inc. price-consensus-eps-surprise-chart | Equifax, Inc. Quote
Factors That Auger Well
Equifax serves a wide range of industries, such as financial, mortgage, consumer, employees, telecommunications, automotive, commercial, retail, government, resellers and others. This diversified client base is extremely beneficial, as weakness in any sector can be balanced with strength in the others.
The company’s top line has shown decent growth rates in the past few years. Total revenues have increased at a compounded annual growth rate of 5.6% from 2016 to 2020. Revenues improved 26% year over year in the second quarter of 2021.
We believe synergies from acquisitions, in addition to continued general consumer credit activity, product innovation, initiatives to foster enterprise growth and efficient business executions, will continue to drive Equifax’s revenues over the long run.
Some Risks
Equifax’s cash and cash equivalent of $458 million at the end of the second quarter was well below the long-term debt level of $3.3 billion, underscoring that the company does not have enough cash to meet this debt burden. The cash level cannot even meet the short-term debt of $601 million.
Zacks Rank and Stocks to Consider
Equifax currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Zacks Business Services sector are ManpowerGroup (MAN - Free Report) , Cross Country Healthcare (CCRN - Free Report) and Genpact (G - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
The long-term expected earnings per share (three to five years) growth rate for ManpowerGroup, Cross Country Healthcare and Genpact is pegged at 24.2%, 9.9% and 14.7%, respectively